Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted tetrazolo[1,5-a]pyrazines and tetrazolo[1,5-c]pyrimidines as adenosine receptor antagonists

Substituted tetrazolo[1,5-a]pyrazines and tetrazolo[1,5-c]pyrimidines as adenosine receptor antagonists

US Patent 12065444 · Granted Aug 20, 2024

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cannabinoid receptor modulators2024
Somatostatin modulators and uses thereof2023
Cannabinoid receptor modulators2023
Cannabinoid receptor modulators2023
Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof2023
Crystalline forms and processes for the preparation of cannabinoid receptor modu2023
Somatostatin modulators and uses thereof2022
Cannabinoid receptor modulators2022
Somatostatin modulators and uses thereof2021
Somatostatin modulators and uses thereof2021
Somatostatin modulators and uses thereof2021
Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof2021